Publication Name	World Journal of Clinical Cases
Manuscript ID	72264
Country	China

Received	2021-10-10 04:50
Peer-Review Started	2021-10-10 04:51
To Make the First Decision
Return for Revision	2021-12-10 02:17
Revised	2021-12-18 17:57
Second Decision	2022-03-08 03:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-03-16 15:41
Articles in Press	2022-03-16 15:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-04-13 08:28
Publish the Manuscript Online	2022-04-30 05:08

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Integrative & Complementary Medicine
Manuscript Type	Case Report
Article Title	Hepatic perivascular epithelioid cell tumor: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Yong-Fang Li, Liang Wang and Yi-Jing Xie
ORCID	Author(s) ORCID Number Yong-Fang Li http://orcid.org/0000-0003-3143-4090 Liang Wang http://orcid.org/0000-0003-1620-7682 Yi-Jing Xie http://orcid.org/0000-0003-0100-4487
Funding Agency and Grant Number
Corresponding Author	Liang Wang, MM, N/A, N/A, hepatology, Lanzhou University Second Hospital,, 82 Cuiying men, Lanzhou 730030, Gansu Province, China. wangliang@lzu.edu.cn
Key Words	Perivascular epithelioid cell tumor; Liver; Treatment; Transarterial embolization; Sorafenib; Case report
Core Tip	Transarterial embolization in combination with sorafenib is a targeted anti-angiogenic therapy that is widely used in the palliative treatment of unresectable hepatocellular carcinoma. However, this combination therapy has not been reported in perivascular epithelioid cell tumor (PEComa). In patients with PEcoma of the liver that cannot be surgically resected or when surgery is contraindicated, this combination of adjuvant therapy is safe and feasible to shrink the tumor and allow the patient to undergo surgery.
Publish Date	2022-04-30 05:08
Citation	Li YF, Wang L, Xie YJ. Hepatic perivascular epithelioid cell tumor: A case report. World J Clin Cases 2022; 10(13): 4273-4279
URL	https://www.wjgnet.com/2307-8960/full/v10/i13/4273.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i13.4273

Full Article (PDF)	WJCC-10-4273.pdf
Full Article (Word)	WJCC-10-4273.docx
CARE Checklist–2016	72264-CARE-Checklist–2016-revision.pdf
Manuscript File	72264_Auto_Edited-LJH.docx
Answering Reviewers	72264-Answering reviewers.pdf
Audio Core Tip	72264-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	72264-Conflict-of-interest statement.pdf
Copyright License Agreement	72264-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	72264-Grant application form(s).pdf
Signed Consent for Treatment Form(s) or Document(s)	72264-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	72264-Language certificate.pdf
Peer-review Report	72264-Peer-review(s).pdf
Scientific Misconduct Check	72264-Bing-Liu JH-2.jpg
Scientific Misconduct Check	72264-CrossCheck.jpg
Scientific Editor Work List	72264-Scientific editor work list.pdf
CrossCheck Report	72264-CrossCheck report.pdf